These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993 [TBL] [Abstract][Full Text] [Related]
5. Validation of the Kumamoto criteria for prediction of Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078 [TBL] [Abstract][Full Text] [Related]
6. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400 [TBL] [Abstract][Full Text] [Related]
8. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis. Gertz MA; Brown ML; Hauser MF; Kyle RA Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031 [TBL] [Abstract][Full Text] [Related]
9. [Bone seeking tracers' scintigraphy for the diagnosis of transthyretin cardiac amyloidosis]. Daquarti GJ; Meretta A; Corneli M; Costabel JP; Diez M; Masoli OH Medicina (B Aires); 2018; 78(6):395-398. PubMed ID: 30504105 [TBL] [Abstract][Full Text] [Related]
10. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis]. Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088 [TBL] [Abstract][Full Text] [Related]
11. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report. Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392 [TBL] [Abstract][Full Text] [Related]
12. Lights and Shadows of Clinical Applications of Cardiac Scintigraphy with Bone Tracers in Suspected Amyloidosis. Saro R; Pavan D; Porcari A; Sinagra G; Mojoli M J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137674 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087 [TBL] [Abstract][Full Text] [Related]
14. Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis. Waheed A; Dorbala S Cardiol Clin; 2023 May; 41(2):217-231. PubMed ID: 37003679 [TBL] [Abstract][Full Text] [Related]
15. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis]. Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892 [TBL] [Abstract][Full Text] [Related]
16. Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis. Park YJ; Lee J; Kim D; Choi JO; Kim SJ; Kim K; Choi JY BMC Med Imaging; 2023 Jul; 23(1):92. PubMed ID: 37460984 [TBL] [Abstract][Full Text] [Related]